Maxim Group analyst Anthony Vendetti reiterated a Buy rating on Electrocore (ECOR – Research Report) yesterday and set a price target of $15.00. The company’s shares closed yesterday at $4.95.
Vendetti covers the Healthcare sector, focusing on stocks such as Biolase, ReShape Lifesciences, and Icecure Medical. According to TipRanks, Vendetti has an average return of -2.3% and a 32.87% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Electrocore with a $16.00 average price target, a 223.23% upside from current levels. In a report released yesterday, H.C. Wainwright also maintained a Buy rating on the stock with a $10.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
The company has a one-year high of $10.20 and a one-year low of $2.93. Currently, Electrocore has an average volume of 31.65K.
Based on the recent corporate insider activity of 34 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of ECOR in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
electroCore, Inc. is a commercial-stage bio-electronic medicine company, with a platform non-invasive vagus nerve stimulation therapy focuses on neurology and rheumatology. The company’s therapy, gammaCore, has pharmacologic effects on the peripheral and central nervous systems, which modulate neurotransmitters and immune function. It focuses on acute treatment of migraine and episodic cluster headache. The company was founded by Joseph P. Errico, Steve Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Morris Plains, NJ.
Read More on ECOR:
- electroCore reports Q1 EPS ($1.03), consensus (96c)
- electroCore Announces Second Quarter 2023 Financial Results
- electroCore, Inc. Announces $8.145 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules
- electroCore to sell 1.68M shares at $4.4125 in registered direct offering
- electroCore announces publication of manuscript on VNS
